We are live on ! Find out more
SRRA

Sierra Oncology, Inc. Common Stock

Delisted

SRRA was delisted on the 30th of June, 2022.

Name Holding Trade Value Shares
Change
Change in
Stake
VC
1
Vivo Capital
California
$23.2M
O
2
OrbiMed
New York
$17.9M
A
3
Abingworth
United Kingdom
$10.5M
CC
4
Caxton Corporation
New Jersey
$7.79M
MP
5
Mangrove Partners
Connecticut
$5.09M -$229K -18,443 -4%
NLVP
6
New Leaf Venture Partners
New York
$4.96M
VA
7
VR Adviser
New York
$4.58M -$1.39M -112,129 -23%
FM
8
Frazier Management
Washington
$2.45M
6CM
9
683 Capital Management
New York
$1.7M
Renaissance Technologies
10
Renaissance Technologies
New York
$1.14M +$118K +9,500 +11%
PA
11
Perceptive Advisors
New York
$807K +$12 +1 +0%
BCM
12
Bridgeway Capital Management
Texas
$425K +$433K +34,907 New
Northern Trust
13
Northern Trust
Illinois
$421K +$431K +34,737 New
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$237K -$54.4K -4,382 -18%
PVI
15
Pura Vida Investments
New York
$229K
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$161K +$30.7K +2,473 +23%
IC
17
Ikarian Capital
Texas
$118K +$120K +9,658 New
TRCT
18
Tower Research Capital (TRC)
New York
$74K +$72.2K +5,816 +1,829%
S
19
SignatureFD
Georgia
$61K +$62K +5,000 New
BlackRock
20
BlackRock
New York
$48K +$49.7K +4,005 New
Morgan Stanley
21
Morgan Stanley
New York
$4K -$1.92K -155 -29%
Group One Trading
22
Group One Trading
Illinois
$3K
Wells Fargo
23
Wells Fargo
California
$2K
PAG
24
Private Advisor Group
New Jersey
$1K +$1.24K +100 New
RE
25
RBC Europe
United Kingdom
$290